hotspot -WSS

hotspot

author：knowledge 2025-09-03 03:35:07 - browse：66

Ed Silverman on the Breakthrough Summit stage in 2023. — STAT's Ed Silverman on stage at the STAT Breakthrough Summit in 2023. Sarah Gonzalez for STAT

In 2023, STAT launched a brand-new home for our subscribers to connect with each other and with their favorite STAT journalists. On STAT+ Connect, you can find job postings; comment on STAT articles (since we have closed comments on article pages); discuss industry events with other people who work in biotech, pharma, public health advocacy, PR, and more; read insights and exclusive material posted by STAT reporters and editors; and watch events, including live interviews and text-based Ask Me Anything chats.

Last week, Ed Silverman, AKA Pharmalot, hosted an AMA titled “Stump Pharmalot.” During the AMA, Ed discussed gene therapy, his proudest career moments, what he took in high school instead of chemistry, coffee (or, as he calls it, “cups of stimulation”), and more.

Below, you can find a lightly edited transcript of the conversation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： FDA investigates CAR

focus

explore

WSS

At JPM 2024, hospital systems pitch financial strength to investors

How to pay for weight loss drugs and save Medicare

30 years of 'Listening to Prozac'

Flagship Pioneering launches a new biotech in two countries

Diagnostic tests are hitting their mathematical limits

What don’t we know about an Alzheimer’s drug side effect?

knowledge

hotspot

focus

Apple is now the first public company to be valued at $3 trillion

Rep. Raul Ruiz on the physician shortage and more

Alkermes shareholders re

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Hollywood unions extend contract negotiations for actors

What don’t we know about an Alzheimer’s drug side effect?

Tori Bowie and the unacceptable rates of Black maternal death

At JPM 2024, hospital systems pitch financial strength to investors

At least 13 dead in Texas as scorching temps continue

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

hotspot

Gene therapy denied for Afghan refugee whose father aided U.S.

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

30 years of 'Listening to Prozac'

American taxpayers paid $1.8 trillion in health care costs in 2022

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Rep. Raul Ruiz on the physician shortage and more

focus

hotspot

explore

explore